# OnCo record paper-boissiere-michot-her2-ultralow-tnbc-virchows-arch-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-boissiere-michot-her2-ultralow-tnbc-virchows-arch-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-boissiere-michot-her2-ultralow-tnbc-virchows-arch-2026" ;
  schema:name "Exploring the spectrum of HER2 in non-metastatic triple negative breast cancer: from HER2-null to HER2-low, including HER2-ultralow status"@en ;
  schema:description "Reclassifying 367 chemotherapy-naive triple-negative cancers put 38% in HER2-null, 38% in HER2-ultralow and 24% in HER2-low; the categories differed a little in size, grade and BRCA1 methylation but not in relapse over ten years."@en ;
  schema:url <https://onco.cc/key-papers/paper-boissiere-michot-her2-ultralow-tnbc-virchows-arch-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s00428-026-04425-1>, <https://pubmed.ncbi.nlm.nih.gov/41636845/> ;
  schema:sameAs <https://doi.org/10.1007/s00428-026-04425-1> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Boissiere-Michot F, Gudin-De-Vallerin A, Thezenas S, et al." ;
  onco:related <https://onco.cc/biomarkers/her2-ultralow/>, <https://onco.cc/biomarkers/her2-low-ihc/>, <https://onco.cc/biomarkers/her2-ihc-0/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:terms <https://onco.cc/terms/her2-low/>, <https://onco.cc/terms/ihc/> .